Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer’s Disease

The disruption of iron metabolism and iron transport proteins have been implicated in the pathogenesis of Alzheimer’s disease (AD). Serum melanotransferrin (MTf), a transferrin homolog capable of reversibly binding iron, has been proposed as a biochemical marker of AD. MTf has also been shown to be...

Full description

Bibliographic Details
Main Authors: Azhaar Ashraf, Jose Andres Alepuz Guillen, Manal Aljuhani, Chantal Hubens, Po-Wah So
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2019.00181/full
_version_ 1818512585839869952
author Azhaar Ashraf
Jose Andres Alepuz Guillen
Manal Aljuhani
Chantal Hubens
Po-Wah So
author_facet Azhaar Ashraf
Jose Andres Alepuz Guillen
Manal Aljuhani
Chantal Hubens
Po-Wah So
author_sort Azhaar Ashraf
collection DOAJ
description The disruption of iron metabolism and iron transport proteins have been implicated in the pathogenesis of Alzheimer’s disease (AD). Serum melanotransferrin (MTf), a transferrin homolog capable of reversibly binding iron, has been proposed as a biochemical marker of AD. MTf has also been shown to be elevated in iron-rich reactive microglia near amyloid plaques in AD. We examined the association of CSF MTf to hippocampal volumes and cognitive tests in 86 cognitively normal, 135 mild cognitive impairment (MCI) and 66 AD subjects. CSF was collected at baseline for MTf, Aβ, total-tau and phosphorylated-tau measurements. Serial cognitive testing with ADAS-Cog13, Rey’s auditory visual learning test (RAVLT), mini-mental state examination (MMSE) were performed alongside hippocampal MRI volumetric analysis for up to 10 years after baseline measurements. High levels of baseline CSF MTf were positively associated with baseline hippocampal volume (R2 = 22%, β = 0.202, and p = 0.017) and RAVLT scores (R2 = 7.30%, β = -0.178, and p = 0.043) and negatively correlated to ADAS-Cog13 (R2 = 17.3%, β = 0.247, and p = 0.003) scores in MCI subjects. Interestingly, MCI subjects that converted to AD demonstrated significantly lower levels of CSF MTf (p = 0.020) compared to MCI non-converters at baseline. We suggest the diminished CSF MTf observed in MCI-converters to AD may arise from impaired transport of MTf from blood into the brain tissue/CSF and/or increased MTf export from the CSF into the blood arising from attenuated competition with reduced levels of CSF Aβ. Further investigations are required to determine the source of CSF MTf and how brain MTf is regulated by cellular barriers, Aβ and activated microglia that surround plaques in AD pathophysiology. In conclusion, low CSF MTf may identify those MCI individuals at risk of converting to AD.
first_indexed 2024-12-10T23:48:53Z
format Article
id doaj.art-2d6002e7c1e547f385edc15df39fa32c
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-12-10T23:48:53Z
publishDate 2019-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-2d6002e7c1e547f385edc15df39fa32c2022-12-22T01:28:51ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2019-03-011310.3389/fnins.2019.00181433053Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer’s DiseaseAzhaar AshrafJose Andres Alepuz GuillenManal AljuhaniChantal HubensPo-Wah SoThe disruption of iron metabolism and iron transport proteins have been implicated in the pathogenesis of Alzheimer’s disease (AD). Serum melanotransferrin (MTf), a transferrin homolog capable of reversibly binding iron, has been proposed as a biochemical marker of AD. MTf has also been shown to be elevated in iron-rich reactive microglia near amyloid plaques in AD. We examined the association of CSF MTf to hippocampal volumes and cognitive tests in 86 cognitively normal, 135 mild cognitive impairment (MCI) and 66 AD subjects. CSF was collected at baseline for MTf, Aβ, total-tau and phosphorylated-tau measurements. Serial cognitive testing with ADAS-Cog13, Rey’s auditory visual learning test (RAVLT), mini-mental state examination (MMSE) were performed alongside hippocampal MRI volumetric analysis for up to 10 years after baseline measurements. High levels of baseline CSF MTf were positively associated with baseline hippocampal volume (R2 = 22%, β = 0.202, and p = 0.017) and RAVLT scores (R2 = 7.30%, β = -0.178, and p = 0.043) and negatively correlated to ADAS-Cog13 (R2 = 17.3%, β = 0.247, and p = 0.003) scores in MCI subjects. Interestingly, MCI subjects that converted to AD demonstrated significantly lower levels of CSF MTf (p = 0.020) compared to MCI non-converters at baseline. We suggest the diminished CSF MTf observed in MCI-converters to AD may arise from impaired transport of MTf from blood into the brain tissue/CSF and/or increased MTf export from the CSF into the blood arising from attenuated competition with reduced levels of CSF Aβ. Further investigations are required to determine the source of CSF MTf and how brain MTf is regulated by cellular barriers, Aβ and activated microglia that surround plaques in AD pathophysiology. In conclusion, low CSF MTf may identify those MCI individuals at risk of converting to AD.https://www.frontiersin.org/article/10.3389/fnins.2019.00181/fullAlzheimer’s diseaseCSFironMCImelanotransferrinmicroglia
spellingShingle Azhaar Ashraf
Jose Andres Alepuz Guillen
Manal Aljuhani
Chantal Hubens
Po-Wah So
Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer’s Disease
Frontiers in Neuroscience
Alzheimer’s disease
CSF
iron
MCI
melanotransferrin
microglia
title Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer’s Disease
title_full Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer’s Disease
title_fullStr Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer’s Disease
title_full_unstemmed Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer’s Disease
title_short Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer’s Disease
title_sort low cerebrospinal fluid levels of melanotransferrin are associated with conversion of mild cognitively impaired subjects to alzheimer s disease
topic Alzheimer’s disease
CSF
iron
MCI
melanotransferrin
microglia
url https://www.frontiersin.org/article/10.3389/fnins.2019.00181/full
work_keys_str_mv AT azhaarashraf lowcerebrospinalfluidlevelsofmelanotransferrinareassociatedwithconversionofmildcognitivelyimpairedsubjectstoalzheimersdisease
AT joseandresalepuzguillen lowcerebrospinalfluidlevelsofmelanotransferrinareassociatedwithconversionofmildcognitivelyimpairedsubjectstoalzheimersdisease
AT manalaljuhani lowcerebrospinalfluidlevelsofmelanotransferrinareassociatedwithconversionofmildcognitivelyimpairedsubjectstoalzheimersdisease
AT chantalhubens lowcerebrospinalfluidlevelsofmelanotransferrinareassociatedwithconversionofmildcognitivelyimpairedsubjectstoalzheimersdisease
AT powahso lowcerebrospinalfluidlevelsofmelanotransferrinareassociatedwithconversionofmildcognitivelyimpairedsubjectstoalzheimersdisease